Genostics® is medical diagnostic, education and consultancy company.
Genostics® partners with world-class cancer research laboratories in Europe to bring the very best in personalised cancer testing medical communities worldwide.
We engage with pioneering practitioners who seek to discover the exact nature of each patient's cancer. These practitioners use Genostics® tests to help design personalised treatment plans and to closely monitor the effectiveness of therapies.
Specialising in the field of Oncology, we are proud to be bringing the future of personalised cancer testing to patients, today.
24 Sept 2015
Dr. Joachim Fluhrer will be presenting at the World CTC Symposium in Melbourne on 10 October 2015. Genostics will be available for general enquiries in the exhibition hall.
Your lifestyle is an on/off switch for your genes ...Find out more
June 30, 2015
Detecting the rare, renaged cancer cells ...Learn more
June 18, 2015
Survival of the fittest in cancer ...Quick view of this blog
June 8, 2015
"Even if surgery, chemotherapy, or radiation removes all traces of known cancer, there is still a risk of the cancer returning, often in a distant location in the body. This may occur as a result of CTCs."
...Read the article
June 2, 2015
Which chemotherapy kills the cells which cause cancer spread, doctor? ...more info
May 18, 2015
Gene expression and the regulation of genes ...Read this article
May 11, 2015
Genetics, explained simply ...Read this blog
May 5, 2015
What is a biomarker, and how are CTCs both defined as biomarkers and carriers of biomarkers? ...Learn more
April 27, 2015
Circulating Tumour Cells: Tell me more ...Quick view
Circulating Tumour Cell Blog
Welcome to the world's first Circulating Tumour Cell blog - written for practitioners and their patients.
Dr. Fluhrer gives NewYou an in-depth look at the intertwined world of cancer testing and molecular medicine.
"In what specific ways can personalised cancer testing and molecular medicine revolutionise the way people treat and think of cancer?
Every person is a separate individual, similarly every cancer is also ‘individual’ to the person affected, in a manner of speaking; cancer is heterogeneous. Cells in a malignant tumour can include cancer stem cells, promoter cells, communication cells, supportive cells, immune cells etc. Some of the cancer cells produce proteins that inhibit the immune system to recognise them and kill it."
...Read the rest of this article
'Best of the best' publication
Prof. Pachmann's poster, outlining the use of Maintrac® technology in uncovering the heterogenous nature of Circulating Tumour Cells, was awarded 'The best of the best' poster at the Clinical Oncology Society of Australia conference. Somatic mutations of the EGFR, KRAS and BRAF genes: homogeneitiy in single cells from cell lines and heterogeneity in Circulating Epithelial Tumor Cells (CETCs) as determined using cobas® z480 analyzer (2014) ...Quick view